CIK 0001533743 · <br>Emerging growth company
Processa Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PCSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 451539785
- Phone
- 443-776-3133
- Business address
- 601 21ST STREET, SUITE 300, VERO BEACH, FL, 32960
- Former names
- Heatwurx, Inc.
- 4 Open-market buy Pres. Research & Development bought 2,067 shares at $2.22 ($4,589)
- 4 Open-market buy Chief Financial Officer bought 2,654 shares at $2.22 ($5,892)
- 4 Open-market buy Chief Executive Officer bought 2,465 shares at $2.22 ($5,472)
- 4 Open-market buy Chief Business - Strategy Off bought 1,831 shares at $2.22 ($4,065)
- 4 Open-market buy Chief Administrative Officer bought 2,118 shares at $2.22 ($4,702)
- 4 Open-market buy Pres. Research & Development bought 1,786 shares at $2.57 ($4,590)
- 4 Open-market buy Chief Financial Officer bought 2,292 shares at $2.57 ($5,890)
- 4 Open-market buy Chief Executive Officer bought 2,129 shares at $2.57 ($5,472)
- 4 Open-market buy Chief Business - Strategy Off bought 1,582 shares at $2.57 ($4,066)
- 4 Open-market buy Chief Administrative Officer bought 1,829 shares at $2.57 ($4,701)
- 4 Open-market buy Chief Executive Officer bought 1,843 shares at $2.97 ($5,474)
- 4 Open-market buy Pres. Research & Development bought 1,545 shares at $2.97 ($4,589)
- 4 Open-market buy Chief Business - Strategy Off bought 1,369 shares at $2.97 ($4,066)
- 4 Open-market buy Chief Administrative Officer bought 1,583 shares at $2.97 ($4,702)
- 4 Open-market buy Chief Financial Officer bought 1,984 shares at $2.97 ($5,892)
- 4/A Open-market buy Chief Executive Officer bought 1,843 shares at $2.97 ($5,474)
- 4/A Open-market buy Chief Development Officer bought 1,971 shares at $2.71 ($5,341)
- 4 Open-market buy Pres. Research & Development bought 1,706 shares at $2.69 ($4,589)
- 4 Open-market buy Chief Financial Officer bought 2,190 shares at $2.69 ($5,891)
- 4 Open-market buy Chief Executive Officer bought 2,034 shares at $2.69 ($5,471)
Page 2 of 15 · 296 filings